Taxolog, Inc.
🇺🇸United States
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2008-05-28
- Lead Sponsor
- Taxolog Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT00685204
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
🇺🇸New York University Cancer Center, New York, New York, United States
News
No news found